Comparison of cardiovascular biomarker expression in extracellular vesicles, plasma and carotid plaque for the prediction of MACE in CEA patients.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
18 01 2023
18 01 2023
Historique:
received:
30
12
2021
accepted:
10
01
2023
entrez:
18
1
2023
pubmed:
19
1
2023
medline:
21
1
2023
Statut:
epublish
Résumé
Extracellular vesicles (EV) are a novel biomarker source for diagnosis and prognosis of cardiovascular disease. A protein comparison of plasma EVs in relation to blood plasma and atherosclerotic plaque has not been performed but would provide insight into the origin and content of biomarker sources and their association with atherosclerotic progression. Using samples of 88 carotid endarterectomy patients in the Athero-Express, 92 proteins (Olink Cardiovascular III panel) were measured in citrate plasma, plasma derived LDL-EVs and atherosclerotic plaque. Proteins were correlated between sources and were related to pre-operative stroke and 3-year major adverse cardiovascular events (MACE). Plasma and EV proteins correlated moderately on average, but with substantial variability. Both showed little correlation with plaque, suggesting that these circulating biomarkers may not originate from the latter. Plaque (n = 17) contained most differentially-expressed proteins in patients with stroke, opposed to EVs (n = 6) and plasma (n = 5). In contrast, EVs contained most differentially-expressed proteins for MACE (n = 21) compared to plasma (n = 9) and plaque (n = 1). EVs appear to provide additional information about severity and progression of systemic atherosclerosis than can be obtained from plasma or atherosclerotic plaque.
Identifiants
pubmed: 36653383
doi: 10.1038/s41598-023-27916-6
pii: 10.1038/s41598-023-27916-6
pmc: PMC9849473
doi:
Substances chimiques
Biomarkers
0
Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1010Informations de copyright
© 2023. The Author(s).
Références
Sci Rep. 2019 Jun 20;9(1):8991
pubmed: 31222168
PLoS One. 2016 Jan 28;11(1):e0148073
pubmed: 26820481
J Vasc Surg. 2005 Dec;42(6):1075-81
pubmed: 16376194
Proteomics. 2012 Feb;12(4-5):722-35
pubmed: 22247067
Int J Mol Sci. 2017 Dec 29;19(1):
pubmed: 29286309
Sci Rep. 2016 May 20;6:26231
pubmed: 27198765
Nat Biotechnol. 2001 Mar;19(3):242-7
pubmed: 11231557
Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228
pubmed: 29339798
Stroke. 2015 Jan;46(1):182-189
pubmed: 25477221
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
Nat Rev Cardiol. 2017 May;14(5):259-272
pubmed: 28150804
Theranostics. 2019 Mar 7;9(7):1851-1863
pubmed: 31037143
Eur J Vasc Endovasc Surg. 2021 Nov;62(5):705-715
pubmed: 34511318
Biomedicines. 2020 Jul 28;8(8):
pubmed: 32731351
Circulation. 2001 Nov 27;104(22):2649-52
pubmed: 11723013
Thromb Haemost. 2014 Oct;112(4):716-26
pubmed: 25007837
PLoS One. 2012;7(9):e45676
pubmed: 23049835
Nat Commun. 2021 May 5;12(1):2536
pubmed: 33953198
Hypertension. 2003 Feb;41(2):211-7
pubmed: 12574084
Diabetologia. 2019 Dec;62(12):2179-2187
pubmed: 31690986
Oxid Med Cell Longev. 2018 Nov 6;2018:4692081
pubmed: 30524655
Atherosclerosis. 2009 Mar;203(1):112-8
pubmed: 18715566
Acta Neurochir Suppl. 2000;76:277-8
pubmed: 11450024
Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):612-9
pubmed: 20018935
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Stroke. 2012 May;43(5):1273-8
pubmed: 22442175
Br J Surg. 2019 Jun;106(7):872-878
pubmed: 30938840
Eur J Epidemiol. 2004;19(12):1127-33
pubmed: 15678794
J Extracell Vesicles. 2021 Sep;10(11):e12140
pubmed: 34520123
Intensive Care Med Exp. 2020 Dec 18;8(Suppl 1):22
pubmed: 33336297
Eur Heart J. 2011 Aug;32(16):2034-41
pubmed: 21186238
Sci Rep. 2020 Jul 23;10(1):12257
pubmed: 32704130